Home
OverviewAbout10 LeapsCollaborationImpact
OverviewLeaps TalksChapter FilmsLeaps.orgPartners
AgricultureHealth
OverviewAnnual ReviewBreakthrough StudyPress ReleasesIn the NewsReportsLeaps LeadershipPress KitMedia Contact
Team
  • Approach
    • Overview
    • About
    • 10 Leaps
    • Collaboration
    • Impact
  • Engagement
    • Overview
    • Leaps Talks
    • Chapter Films
    • Leaps.org
    • Partners
    • Agriculture
    • Health
  • News
    • Overview
    • Annual Review
    • Breakthrough Study
    • Press Releases
    • In the News
    • Reports
    • Leaps Leadership
    • Press Kit
    • Media Contact
  • Team
ContactImprintPrivacy StatementConditions of Use
sign up for our newsletter
see more companies

Nextpoint Therapeutics

nextpoint therapeutics health logo

Vision

Developing a new world of precision immuno-oncology.

Approach

NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Its innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors.

Nextpoint Therapeutics is addressing

  • Leap 04 / Prevent and cure cancer

CEO:

Detlev Biniszkiewicz, PhD

Founders:

XingXing Zang, PhD

Gordon Freeman, PhD

First investment:

December 2022

nextpointtx.com